| 000 | 01274pam a2200337 i 4500 | ||
|---|---|---|---|
| 999 |
_c12496 _d12496 |
||
| 001 | 1089915 | ||
| 005 | 20210222163541.0 | ||
| 008 | 921215s1993 flua b 001 0 eng d | ||
| 010 | _a 92045675 | ||
| 020 | _a0849344476 (acidfree paper) | ||
| 040 |
_aEG-NcFUE _erda |
||
| 043 | _an-us--- | ||
| 050 | 0 | 0 |
_aRM301.25 _b.L44 1993 |
| 082 | 0 | 0 |
_a615.19 _222 _bL.C.D |
| 100 | 1 |
_aLee, Chi-Jen. _eauthor. |
|
| 245 | 1 | 0 |
_aDevelopment and evaluation of drugs : _bfrom laboratory through licensure to market / _cChi-Jen Lee (Center for biologics evaluation and research, United States food and drug administration, Bethesda, Maryland) |
| 264 | 1 |
_aBoca Raton : _bCRC Press, _c[1993] |
|
| 264 | 4 | _c©1993 | |
| 300 |
_a226 pages : _billustrations ; _c25 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrugs _xResearch. |
|
| 650 | 0 |
_aDrugs _xLaw and legislation _zUnited States. |
|
| 650 | 0 | _aPharmaceutical industry. | |
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||